Aspirin treatment does not attenuate platelet or leukocyte activation as monitored by whole blood flow cytometry
about
The antithrombotic profile of aspirin. Aspirin resistance, or simply failure?The role of platelets in the recruitment of leukocytes during vascular diseaseWhole blood flow cytometry measurements of in vivo platelet activation in critically-Ill patients are influenced by variability in blood sampling techniques.Hydroxychavicol, a novel betel leaf component, inhibits platelet aggregation by suppression of cyclooxygenase, thromboxane production and calcium mobilizationUnaltered Angiogenesis-Regulating Activities of Platelets in Mild Type 2 Diabetes Mellitus despite a Marked Platelet HyperreactivityNovel uses for anti-platelet agents as anti-inflammatory drugs.Persistent versus transient depressive symptoms in relation to platelet hyperactivation: a longitudinal analysis of dementia caregivers.Current concepts of platelet activation: possibilities for therapeutic modulation of heterotypic vs. homotypic aggregation.A platelet-inspired paradigm for nanomedicine targeted to multiple diseases.Why does aspirin decrease the risk of venous thromboembolism? On old and novel antithrombotic effects of acetyl salicylic acid.Platelet activation in essential hypertension: implications for antiplatelet treatment.Expression of EMMPRIN (CD147) on circulating platelets in vivo.Thrombin-Mediated Platelet Activation of Lysed Whole Blood and Platelet-Rich Plasma: A Comparison Between Platelet Activation Markers and Ultrastructural Alterations.Trans-vessel gradient of myeloperoxidase in coronary artery disease.Leukocyte-platelet aggregates-a phenotypic characterization of different stages of peripheral arterial disease.Amicus or Adversary Revisited: Platelets in Acute Lung Injury & Acute Respiratory Distress Syndrome.
P2860
Q24794673-5D6BF27A-76FF-4100-82E3-C7553284427EQ26801407-5BBE8F6E-570B-4AAD-BC78-D10B3D24A7C7Q35881752-59458E02-0A3F-4651-A241-B7A0CB6DD538Q35995270-249A40BB-6466-4BA6-BC95-A823B1163F5CQ36128546-E7EAB753-5375-479B-81A6-0B58B2D70AE8Q36171374-6FE142BA-D6C2-4CE2-9115-36820B92DE64Q37409451-7AAEFB60-2185-47AD-9EC4-FA04CF538074Q37827566-E71ED1E4-64A5-4CE9-BE3D-589AF314D002Q38145567-902060AA-8BA7-4E0B-ADFF-805C2937BCCFQ38248477-A2E10016-A828-4F77-AF50-D7D83B848E18Q43186392-065EC932-9A08-41FA-A7F6-5661B17E5B51Q43227478-F851FE98-46C6-4A22-9AF3-B1DA78A4FDCDQ46444246-59C6514F-3339-4F42-AE16-C67CE68A1C01Q47977423-2C625E30-0C72-4CBD-84C8-5B54FB2AD29AQ51676408-06A05FF2-17BA-4500-B0AB-A55619F98A21Q52350643-B99399EE-6019-44DD-AF61-DBD894EC0DAE
P2860
Aspirin treatment does not attenuate platelet or leukocyte activation as monitored by whole blood flow cytometry
description
2003 nî lūn-bûn
@nan
2003 թուականին հրատարակուած գիտական յօդուած
@hyw
2003 թվականին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Aspirin treatment does not att ...... by whole blood flow cytometry
@ast
Aspirin treatment does not att ...... by whole blood flow cytometry
@en
Aspirin treatment does not att ...... by whole blood flow cytometry
@nl
type
label
Aspirin treatment does not att ...... by whole blood flow cytometry
@ast
Aspirin treatment does not att ...... by whole blood flow cytometry
@en
Aspirin treatment does not att ...... by whole blood flow cytometry
@nl
prefLabel
Aspirin treatment does not att ...... by whole blood flow cytometry
@ast
Aspirin treatment does not att ...... by whole blood flow cytometry
@en
Aspirin treatment does not att ...... by whole blood flow cytometry
@nl
P3181
P1433
P1476
Aspirin treatment does not att ...... by whole blood flow cytometry
@en
P2093
P304
P3181
P356
10.1016/J.THROMRES.2003.08.026
P407
P577
2003-01-01T00:00:00Z